Advances in hepatitis C treatment. Why aren’t they being used?
The really incredible advances in the treatment of hepatitis C bring to life several relevant questions as we move forward into 2015. First, who should be treating hepatitis C patients (primary care providers, gastroenterologists, infectious disease specialists)? Second, can we really afford to use these new treatments? I recently discussed this topic with my GI and hepatology colleagues in AGA Perspectives, the bi-monthly opinion magazine of the American …
Advances in hepatitis C treatment. Why aren’t they being used?



![Insulin resistance is a survival mechanism, not a broken system [PODCAST]](https://kevinmd.com/wp-content/uploads/f0ec64bb-ddab-408b-9ef4-106f63883b83-190x100.jpeg)





![Politics and fear have replaced science in U.S. pain management [PODCAST]](https://kevinmd.com/wp-content/uploads/11c2db8f-2b20-4a4d-81cc-083ae0f47d6e-190x100.jpeg)






